Hepatitis C inhibitors and uses thereof

US9453007B2 · kind B2 · utility

Assignees

• Abb Vie Inc. · US
• ABBOTT PRODUCTS GMBH · DE

Inventors

• Clarence J. Maring · Libertyville, US
• John K. Pratt · Kenosha, US
• William A. Carroll · Evanston, US
• Dachun Liu · Vernon Hills, US
• David A. Betebenner · Lawrenceville, US
• Douglas K. Hutchinson · Antioch, US
• Michael D. Tufano · Chicago, US
• Todd W. Rockway · Gurnee, US
• Uwe Schoen · Burgdorf, DE
• Axel Pahl · Winsen (Aller), DE
• Andreas Witte · Hannover, DE

Key dates

• Filing date: Sep 14, 2015
• Grant date: Sep 27, 2016
• Expiry date: Sep 14, 2035

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10T137/86421
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.